Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
DIANT Pharma has developed proprietary continuous nanoparticle/LNP manufacturing platforms, including the GMP-capable LiFT system. Their systems are used by biopharma companies and research organizations to enable scalable, high-throughput production of lipid nanoparticles for applications such as mRNA therapeutics and vaccines. In 2023, the FDA purchased their LiFT system to advance research in continuous LNP manufacturing[1][2][4].
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on DIANT Pharma.